Back to Fayez Sarofim & Co. Fayez Sarofim & Co.

LLY

31 quarters

Position history for Fayez Sarofim & Co.Fayez Sarofim & Co.'s holdings in Eli Lilly and Company

Yes. Fayez Sarofim holds 425,688 shares of LLY (Eli Lilly), worth $510.6M, as of its Q2 2026 13F filing. It increased the position by 2,515 shares (+0.6%) from Q1 2026. Fayez Sarofim has held LLY in every 13F on record since Q4 2018, 31 quarterly filings. LLY is 1.2% of Fayez Sarofim's reported 13F portfolio.

Current Value

$510.6M

Current Shares

425,688

Total Value Change

+$508.8M

Total Shares Change

+410,291

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
425,688
+0.6%
$510.6M1.2%$1,197.71
50
2026-Q1
Decreased
423,173
-0.3%
$389.2M1.0%$916.88
0
2025-Q4
Decreased
424,396
-2.7%
$456.1M1.1%$1,069.51
0
2025-Q3
Increased
436,162
+2.5%
$332.8M0.8%$758.22
45
2025-Q2
Decreased
425,640
-4.0%
$331.8M0.8%$772.95
0
2025-Q1
Increased
443,587
+12.2%
$366.4M0.9%$817.26
49
2024-Q4
Increased
395,297
+7.5%
$305.2M0.7%$762.60
47
2024-Q3
Increased
367,875
+10.9%
$325.9M0.8%$873.71
48
2024-Q2
Increased
331,739
+8.3%
$300.4M0.8%$891.63
47
2024-Q1
Increased
306,469
+0.3%
$238.4M0.7%$764.84
43
2023-Q4
Increased
305,397
+13.5%
$226M0.7%$572.09
49
2023-Q3
Increased
269,155
+15.4%
$144.6M0.5%$526.18
42
2023-Q2
Increased
233,187
+17.0%
$109.4M0.4%$458.43
42
2023-Q1
Increased
199,278
+37.5%
$68.4M0.2%$334.83
46
2022-Q4
Increased
144,952
+320.3%
$53M0.2%$355.54
57
2022-Q3
Increased
34,485
+1.3%
$11.2M0.0%$313.37
28
2022-Q2
Increased
34,060
+3.6%
$11M0.0%$313.20
29
2022-Q1
Increased
32,870
+3.6%
$9.4M0.0%$275.70
29
2021-Q4
Increased
31,722
+7.8%
$8.8M0.0%$264.82
30
2021-Q3
Decreased
29,421
-0.5%
$6.8M0.0%$220.80
0
2021-Q2
Increased
29,577
+6.8%
$6.8M0.0%$218.63
29
2021-Q1
Decreased
27,683
-13.1%
$5.2M0.0%$177.17
0
2020-Q4
Decreased
31,857
-2.4%
$5.4M0.0%$159.46
0
2020-Q3
Increased
32,622
+26.0%
$4.8M0.0%$139.08
33
2020-Q2
Decreased
25,892
-35.8%
$4.3M0.0%$153.51
0
2020-Q1
Increased
40,358
+1.0%
$5.6M0.0%$129.10
27
2019-Q4
Increased
39,972
+141.9%
$5.3M0.0%$121.68
44
2019-Q3
Increased
16,522
+0.3%
$1.8M0.0%$102.95
26
2019-Q2
Decreased
16,477
-78.3%
$1.8M0.0%$101.42
0
2019-Q1
Increased
76,083
+394.1%
$9.9M0.1%$118.12
45
2018-Q4
First report
15,397
-
$1.8M0.0%$104.77
0

Other major holders of LLY: Lilly Endowment Inc., Vanguard Group Inc.

Optional analytics helps us improve. How it’s used